Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
https://techcrunch.com/wp-content/uploads/2015/02/cropped-cropped-favicon-gradient.png?w=32
https://techcrunch.com/wp-content/uploads/2015/02/cropped-cropped-favicon-gradient.png?w=32
Comments
Post a Comment